Optimal Dosing Ranges of Antipsychotics for Adolescents

Initial Dosing Strategy

The American Academy of Child and Adolescent Psychiatry recommends starting risperidone at 0.5-1 mg/day for adolescents, which is substantially lower than adult doses 1
Gradual titration of risperidone is essential to minimize extrapyramidal symptoms and improve adherence in adolescents 1
The initial dose of quetiapine for adolescents should be 25-50 mg/day, based on general pediatric practice 2

Adolescents require lower doses than adults to achieve therapeutic effect, according to the American Academy of Child and Adolescent Psychiatry 1
Initial dosing should begin at the lower end of the range, with increases only after 14-21 days if response is inadequate, as recommended by the British Journal of Psychiatry 3
Rapid dose escalation increases the risk of adverse effects without hastening recovery in adolescents 1

The maximum dose of risperidone for first-episode psychosis in adolescents should not exceed 4-6 mg/day, according to the British Journal of Psychiatry 3
Higher doses of risperidone increase extrapyramidal symptoms without additional benefit in adolescents 1

Extrapyramidal symptoms should be avoided to encourage future medication adherence in adolescents, as recommended by the British Journal of Psychiatry 3
Prolactin levels should be monitored, particularly with risperidone, due to its potential to significantly increase serum prolactin in adolescents 1

A minimum of 4-6 weeks at adequate dosage is recommended before determining medication efficacy in adolescents, according to the American Academy of Child and Adolescent Psychiatry 1
Most patients with schizophrenia require long-term antipsychotic therapy to prevent relapse, with approximately 65% of patients relapsing within 1 year without medication versus 30% with continued treatment 1

Starting at adult doses should be avoided, as adolescents are more sensitive to both therapeutic and adverse effects, according to the American Academy of Child and Adolescent Psychiatry and the British Journal of Psychiatry 1, 3
Rapid titration should be avoided, as it increases side effects without improving outcomes in adolescents 1
Monitor for behavioral activation and suicidality, particularly during the first weeks of treatment, as recommended by the Pediatrics journal 2